| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jérôme de Seze, Frederic Blanc, Luc Jeanjean, Hélène Zéphir, Pierre Labauge, Marie Bouyon, Laurent Ballonzoli, Giovanni Castelnovo, Marie Fleury, Sabine Defoort, Patrick Vermersch, Claude Spee. Optical coherence tomography in neuromyelitis optica. Archives of neurology. vol 65. issue 7. 2008-08-04. PMID:18625858. |
neuromyelitis optica (nmo) is an inflammatory disease with combined features of optic neuritis and myelitis. |
2008-08-04 |
2023-08-12 |
Not clear |
| Lahar R Mehta, Melissa K Samuelsson, Anatole K Kleiner, Andrew D Goodman, Jennifer H Anolik, R John Looney, Steven R Schwi. Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome. Multiple sclerosis (Houndmills, Basingstoke, England). vol 14. issue 3. 2008-08-01. PMID:18208886. |
neuromyelitis optica (nmo) is a demyelinating disease of the central nervous system characterized by severe episodes of optic nerve and spinal cord inflammation. |
2008-08-01 |
2023-08-12 |
Not clear |
| Takahiko Said. [Overview of MS: proposal of new MS definition/classification and review of the results of recent clinical trials]. Nihon rinsho. Japanese journal of clinical medicine. vol 66. issue 6. 2008-07-29. PMID:18540351. |
recurrent devic' s neuromyelitis optica (nmo) and asian optic-spinal multiple sclerosis (ms) used to be defined as a syndrome with selective clinical optic-spinal presentation. |
2008-07-29 |
2023-08-12 |
Not clear |
| Kazuo Fujihar. [Update on the etiology and pathogenesis of multiple sclerosis and neuromyelitis optica]. Nihon rinsho. Japanese journal of clinical medicine. vol 66. issue 6. 2008-07-29. PMID:18540352. |
recent findings on the etiology and pathogenesis of multiple sclerosis (ms) and neuromyelitis optica (nmo) were reviewed. |
2008-07-29 |
2023-08-12 |
Not clear |
| Tatsuo Kohriyama, Kazuhide Ochi, Masayasu Matsumot. [Interferon-beta treatment for multiple sclerosis and predictors of response]. Nihon rinsho. Japanese journal of clinical medicine. vol 66. issue 6. 2008-07-29. PMID:18540357. |
in some patients with neuromyelitis optica (nmo)/osms patients with anti-aquaporin-4 (apq4) antibody or longitudinally extensive spinal cord lesions (lescls) extending over three vertebral segments as well as in patients with collagen disease, ifnbeta has been found to be ineffective or detrimental. |
2008-07-29 |
2023-08-12 |
Not clear |
| Cristina Panea, Simona Petrescu, Pop Monica, Liliana Voinea, Ana-Maria Dascălu, Miruna Nicolae, E Ungureanu, Aida Panca, Sânziana Grădinar. [Diagnostic criteria in acute neuromyelitis]. Oftalmologia (Bucharest, Romania : 1990). vol 51. issue 4. 2008-07-28. PMID:18543687. |
the recently identified serum antibody biomarker: neuromyelitis optica immunoglobulin g (nmo ig g), which target aquaporin 4 water channel, distinguish neuromyelitis optica from multiple sclerosis, is one of the revised criteria of neuromyelitis optica. |
2008-07-28 |
2023-08-12 |
Not clear |
| Tatsuro Misu, Kazuo Fujihara, Yasuto Itoyam. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview]. Brain and nerve = Shinkei kenkyu no shinpo. vol 60. issue 5. 2008-07-24. PMID:18516975. |
neuromyelitis optica (nmo) is an inflammatory disease mainly affecting optic and spinal cords, and was originally described by devic in 1894. |
2008-07-24 |
2023-08-12 |
mouse |
| A McKeon, V A Lennon, T Lotze, S Tenenbaum, J M Ness, M Rensel, N L Kuntz, J P Fryer, H Homburger, J Hunter, B G Weinshenker, K Krecke, C F Lucchinetti, S J Pittoc. CNS aquaporin-4 autoimmunity in children. Neurology. vol 71. issue 2. 2008-07-22. PMID:18509092. |
in adult patients, autoantibodies targeting the water channel aquaporin-4 (aqp4) are a biomarker for a spectrum of cns inflammatory demyelinating disorders with predilection for optic nerves and spinal cord (neuromyelitis optica [nmo]). |
2008-07-22 |
2023-08-12 |
Not clear |
| Sheri E Hamnik, Lotfi Hacein-Bey, José Biller, Gregory Gruener, Walter Ja. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations. Seminars in ophthalmology. vol 23. issue 3. 2008-07-17. PMID:18432545. |
neuromyelitis optica (nmo) antibody positivity in patients with transverse myelitis and no visual manifestations. |
2008-07-17 |
2023-08-12 |
Not clear |
| Sheri E Hamnik, Lotfi Hacein-Bey, José Biller, Gregory Gruener, Walter Ja. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations. Seminars in ophthalmology. vol 23. issue 3. 2008-07-17. PMID:18432545. |
to describe a subgroup of patients with igg antibody to aquaporin 4 protein (aqp4) specific to neuromyelitis optica (nmo), who did not have clinical manifestations of optic nerve involvement at the time of diagnosis. |
2008-07-17 |
2023-08-12 |
Not clear |
| Sean J Pittock, Vanda A Lenno. Aquaporin-4 autoantibodies in a paraneoplastic context. Archives of neurology. vol 65. issue 5. 2008-07-15. PMID:18474738. |
the neuromyelitis optica igg autoantibody (nmo-igg) is a validated biomarker for nmo and an emerging spectrum of inflammatory central nervous system-demyelinating disorders. |
2008-07-15 |
2023-08-12 |
Not clear |
| Rina Takano, Tatsuro Misu, Toshiyuki Takahashi, Masahiro Izumiyama, Kazuo Fujihara, Yasuto Itoyam. A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica. The Tohoku journal of experimental medicine. vol 215. issue 1. 2008-07-01. PMID:18509235. |
neuromyelitis optica (nmo) is a neurologic disease characterized by severe optic neuritis, longitudinally extended, transverse myelitis and serum aquaporin-4 (aqp4) antibody. |
2008-07-01 |
2023-08-12 |
Not clear |
| Bin Zhang, Ying Jiang, Yu Yang, Fuhua Peng, Xueqiang H. Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica. Neuro endocrinology letters. vol 29. issue 2. 2008-06-25. PMID:18404143. |
the aim of this study is to assess serum levels of thyroid hormones (th) and complement c3, c4, ch50 in patients with multiple sclerosis (ms) and neuromyelitis optica (nmo), and investigate whether there is a correlation between serum th and complement factors in these patients. |
2008-06-25 |
2023-08-12 |
Not clear |
| Robert A Wilcox, James Burrow, Mark Slee, Jamie Craig, Dominic Thyagaraja. Neuromyelitis optica (Devic's disease) in a patient with syphilis. Multiple sclerosis (Houndmills, Basingstoke, England). vol 14. issue 2. 2008-06-18. PMID:17986508. |
he initially responded well to penicillin and corticosteriod treatment, but went on to develop the clinical syndrome of neuromyelitis optica (nmo). |
2008-06-18 |
2023-08-12 |
Not clear |
| M Matiello, V A Lennon, A Jacob, S J Pittock, C F Lucchinetti, D M Wingerchuk, B G Weinshenke. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. vol 70. issue 23. 2008-06-16. PMID:18434643. |
to determine the prognostic value of neuromyelitis optica (nmo)-immunoglobulin g (igg) in patients with recurrent optic neuritis (on). |
2008-06-16 |
2023-08-12 |
Not clear |
| M Nakamura, I Miyazawa, K Fujihara, I Nakashima, T Misu, S Watanabe, T Takahashi, Y Itoyam. Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study. Journal of neurology. vol 255. issue 2. 2008-05-28. PMID:18231705. |
to delineate the mri features that distinguish neuromyelitis optica (nmo) from multiple sclerosis (ms). |
2008-05-28 |
2023-08-12 |
Not clear |
| Nathan P Young, Brian G Weinshenker, Claudia F Lucchinett. Acute disseminated encephalomyelitis: current understanding and controversies. Seminars in neurology. vol 28. issue 1. 2008-04-23. PMID:18256989. |
available diagnostic criteria do not reliably distinguish it from first presentations of relapsing diseases such as multiple sclerosis (ms) and neuromyelitis optica (nmo). |
2008-04-23 |
2023-08-12 |
Not clear |
| Sean J Pittoc. Neuromyelitis optica: a new perspective. Seminars in neurology. vol 28. issue 1. 2008-04-23. PMID:18256990. |
the traditional view of neuromyelitis optica (nmo) as a monophasic inflammatory disorder that affects both the optic nerves and the spinal cord is expanding. |
2008-04-23 |
2023-08-12 |
Not clear |
| B Jordan, K Eger, M E Kornhuber, S Zier. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies]. Fortschritte der Neurologie-Psychiatrie. vol 76. issue 1. 2008-04-09. PMID:18189220. |
neuromyelitis optica (nmo; devic's syndrome) is an idiopathic, often relapsing, severe inflammatory disorder preferentially affecting optic nerves and spinal cord. |
2008-04-09 |
2023-08-12 |
Not clear |
| Charles M Poser, Vesna V Brina. The accuracy of prevalence rates of multiple sclerosis: a critical review. Neuroepidemiology. vol 29. issue 3-4. 2008-04-07. PMID:18042998. |
neuromyelitis optica (nmo) has long been considered an ms variant and in far eastern countries it is counted as the 'oriental' form of ms, falsely inflating prevalence rates of ms in those areas. |
2008-04-07 |
2023-08-12 |
Not clear |